Listing 1 - 10 of 17 | << page >> |
Sort by
|
Choose an application
A signature feature of living organisms is their ability to carry out purposeful actions by taking stock of the world around them. To that end, cells have an arsenal of signaling molecules linked together in signaling pathways, which switch between inactive and active conformations. The Molecular Switch articulates a biophysical perspective on signaling, showing how allostery—a powerful explanation of how molecules function across all biological domains—can be reformulated using equilibrium statistical mechanics, applied to diverse biological systems exhibiting switching behaviors, and successfully unify seemingly unrelated phenomena.Rob Phillips weaves together allostery and statistical mechanics via a series of biological vignettes, each of which showcases an important biological question and accompanying physical analysis. Beginning with the study of ligand-gated ion channels and their role in problems ranging from muscle action to vision, Phillips then undertakes increasingly sophisticated case studies, from bacterial chemotaxis and quorum sensing to hemoglobin and its role in mammalian physiology. He looks at G-protein coupled receptors as well as the role of allosteric molecules in gene regulation. Phillips concludes by surveying problems in biological fidelity and offering a speculative chapter on the relationship between allostery and biological Maxwell demons.Appropriate for graduate students and researchers in biophysics, physics, engineering, biology, and neuroscience, The Molecular Switch presents a unified, quantitative model for describing biological signaling phenomena.
Cellular signal transduction. --- Cellular control mechanisms. --- Cell regulation --- Biological control systems --- Cell metabolism --- Cellular information transduction --- Information transduction, Cellular --- Signal transduction, Cellular --- Bioenergetics --- Cellular control mechanisms --- Information theory in biology --- Alexander Gann. --- Bohr effect. --- Bruce Mayer. --- Cell Signaling. --- Genes and Signals. --- MWC enzymes. --- Mark Ptashne. --- Michaelis-Menten Enzymes. --- Tony Pawson. --- Wendell Lim. --- allosterome. --- bacterial aerotaxis. --- cyclic nucleotide gated channels. --- enzyme phenomenology. --- gene expression. --- genome packing. --- glycolosis. --- ligand-receptor binding. --- logic gates. --- membrane receptors. --- nucleosomes. --- phoshofructokinase. --- signal transduction.
Choose an application
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated from bats; however, different from SARS-CoV, which potentially utilized palm civets as its intermediate hosts, MERS-CoV likely transmits to humans through dromedary camels. Animal models, such as humanized mice and nonhuman primates, have been developed for studying MERS-CoV infection. Currently, there are no vaccines and therapeutics approved for the prevention and treatment of MERS-CoV infection, although a number of them have been developed preclinically or tested clinically. This book covers one editorial and 16 articles (including seven review articles and nine original research papers) written by researchers working in the field of MERS-CoV. It describes the following three main aspects: (1) MERS-CoV epidemiology, transmission, and pathogenesis; (2) current progress on MERS-CoV animal models, vaccines, and therapeutics; and (3) challenges and future prospects for MERS-CoV research. Overall, this book will help researchers in the MERS-CoV field to further advance their work on the virus. It also has important implications for other coronaviruses as well as viruses outside the coronavirus family with pandemic potentials.
cell–cell fusion --- hDPP4 --- n/a --- therapeutics --- animal models --- HCoV-229E --- Drivers --- camels --- rabbits --- SARS-CoV --- MERS-CoV --- MVA vaccine --- transmission --- RBD --- MERS-CoV nucleocapsid protein --- complement --- animal model --- pseudotyped virus --- combination --- MERS-coronavirus --- peptide --- mouse model --- spike protein --- receptor-binding domain --- prevention and treatment --- coronaviruses --- coronavirus spike glycoprotein --- therapeutic antibodies --- vaccine platforms --- mutation --- severe acute respiratory syndrome coronavirus --- pathogenesis --- fusion inhibitor --- Coronavirus --- murine CD8+ T cell epitope --- lipidomics --- authentic virus --- correlates of immunity --- vaccines --- neutralizing monoclonal antibodies --- Middle East respiratory syndrome coronavirus --- small-molecule inhibitor --- Middle East Respiratory Syndrome Virus --- DPP4 --- pyroptosis --- cross-neutralization --- inflammation --- Qatar --- spike proteins --- One Health --- HKU4 --- nanobodies --- mechanism of action --- neutralizing antibody --- host factors --- UHPLC–MS
Choose an application
COVID-19 diagnostic strategies based on advanced techniques are currently essential topics of interest, with crucial roles in scientific research. This book integrates fundamental concepts and critical analyses that explore the progress of modern methods for the detection of SARS-CoV-2.
Research & information: general --- Biology, life sciences --- biosensor --- COVID-19 diagnosis --- SARS-CoV-2 --- surface plasmon resonance --- field-effect transistor --- electrochemical --- a point-of-care device --- immunochromatography --- test strips --- surface antigen --- Raman spectra --- nucleocapsid protein --- signal amplification --- copper deposition --- neutralizing antibody --- latex microspheres --- lateral flow immunoassay --- receptor binding domain --- COVID-19 --- microfluidic --- chip --- biosensors --- diagnostics --- spike glycoprotein --- epitope --- electrochemical biosensor --- point of care --- immunological diagnostic --- SARSC-CoV-2 --- surface plasmonic resonance (SPR) --- spike protein --- point-of-care testing --- photonics --- antibodies --- serology --- SH-SAW biosensor --- vaccine --- antibody --- seroprevalence --- humoral immunity --- microfluidics --- clinical decision support tool --- optical biosensors --- machine learning --- nonlinear optics --- diagnosis --- n/a
Choose an application
Pharmacology. Therapy --- Adrenergic mechanisms --- Adrenergic receptors --- Radioligand assay --- Receptors, Adrenergic --- Binding sites --- Adrenaline --- Radioligand Assay --- BINDING SITES --- RECEPTORS, ADRENERGIC --- Receptors --- Binding Sites. --- Radioligand Assay. --- Receptors, Adrenergic. --- -Adrenergic mechanisms --- #Lilly --- Binding assay, Radioligand --- Competitive protein binding assay --- Ligand binding assay (Biochemistry) --- Protein binding assay --- Radioreceptor assay --- Receptor binding assay --- Tissue receptor assay --- Analytical biochemistry --- Ligand binding (Biochemistry) --- Protein binding --- Sympathetic nervous system --- Adrenalin --- Epinephrine --- Bronchodilator agents --- Catecholamines --- Neurotransmitters --- Sympathomimetic agents --- Adrenergic Receptor --- Epinephrine Receptors --- Norepinephrine Receptors --- Adrenergic Receptors --- Adrenoceptors --- Receptors, Epinephrine --- Receptors, Norepinephrine --- Receptor, Adrenergic --- Norepinephrine --- Sympathomimetics --- Racepinephrine --- Protein-Binding Radioassay --- Radioreceptor Assay --- Assay, Radioligand --- Assay, Radioreceptor --- Assays, Radioligand --- Assays, Radioreceptor --- Protein Binding Radioassay --- Protein-Binding Radioassays --- Radioassay, Protein-Binding --- Radioassays, Protein-Binding --- Radioligand Assays --- Radioreceptor Assays --- Ligands --- Protein Binding --- Binding Site --- Combining Site --- Combining Sites --- Site, Binding --- Site, Combining --- Sites, Binding --- Sites, Combining --- Protein Interaction Mapping --- Receptors. --- Binding Sites --- Adrenoreceptors --- Adrenoceptor --- Norepinephrine Receptor --- Receptor, Norepinephrine --- Adrenaline - Receptors
Choose an application
Phages have shown a high biotechnological potential with numerous applications. The advent of high-resolution microscopy techniques aligned with omic and molecular tools have revealed innovative phage features and enabled new processes that can be further exploited for biotechnological applications in a wide variety of fields. The high-quality original articles and reviews presented in this Special Issue demonstrate the incredible potential of phages and their derived proteins in a wide range of biotechnological applications for human benefit. Considering the emergence of amazing new available bioengineering tools and the high abundance of phages and the multitude of phage proteins yet to be discovered and studied, we believe that the upcoming years will present us with many more fascinating and new previously unimagined phage-based biotechnological applications.
toxicity --- encapsulation --- n/a --- cancerous tumors --- bacteriophage-derived lytic enzyme --- native gel electrophoresis --- bacteriophages --- Cpl-1 --- O-antigen --- ESKAPE --- Clostridium perfringens --- X-ray crystallography --- macromolecular interactions --- safety --- biofilm --- major coat protein --- Streptococcus agalactiae --- Staphylococcus aureus --- tail sheath protein --- magnetic separation --- serotyping --- pathogenic viruses --- liposomes --- tuberculosis --- Listeria monocytogenes --- nanotubular structures --- alpha-sheet --- biosensors --- sarcoidosis --- tailspike proteins --- M13 bacteriophage --- Streptococcus pneumoniae --- gene expression regulation --- bacteriophage recombination --- self-assembly --- phage therapy --- R-type pyocin --- contractile injection systems --- bacteriophage vB_EcoM_FV3 --- microtiter plate assay --- Enterococcus faecalis --- culture enrichment --- drug delivery vehicles --- neurodegenerative disease --- landscape phage --- niosomes --- bacteriophage --- Myoviridae --- bacteriophage evolution --- porous structure --- phage-host interaction --- phage display --- immune response --- antibiotic resistance --- Pseudomonas aeruginosa --- phage --- bacteriocin --- Appelmans --- fluorescence sensor --- molecular probe --- nanomedicine --- Shigella flexneri --- reporter phage --- filters --- in vitro activity --- capsid dynamics --- immunoscreening --- diagnostics --- microarray --- receptor-binding protein --- endolysin --- enzybiotics --- transfersomes --- T7phage library --- Pal
Choose an application
Proteins represent one of the most abundant classes of biological macromolecules and play crucial roles in a vast array of physiological and pathological processes. The knowledge of the 3D structure of a protein, as well as the possible conformational transitions occurring upon interaction with diverse ligands, are essential to fully comprehend its biological function.In addition to globular, well-folded proteins, over the past few years, intrinsically disordered proteins (IDPs) have received a lot of attention. IDPs are usually aggregation-prone and may form toxic amyloid fibers and oligomers associated with several human pathologies. Peptides are smaller in size than proteins but similarly represent key elements of cells. A few peptides are able to work as tumor markers and find applications in the diagnostic and therapeutic fields. The conformational analysis of bioactive peptides is important to design novel potential drugs acting as selective modulators of specific receptors or enzymes. Nevertheless, synthetic peptides reproducing different protein fragments have frequently been implemented as model systems in folding studies relying on structural investigations in water and/or other environments.This book contains contributions (seven original research articles and five reviews published in the journal Molecules) on the above-described topics and, in detail, it includes structural studies on globular folded proteins, IDPs and bioactive peptides. These works were conducted usingdifferent experimental methods.
Research & information: general --- mass spectrometric epitope mapping --- gas phase immune complex dissociation --- apparent gas phase dissociation constants --- apparent gas phase activation energies --- ITEM-TWO --- native mass spectrometry --- TRIOBP --- cancer --- deafness --- hearing loss --- mental illness --- schizophrenia --- actin --- cytoskeleton --- disordered structure --- protein aggregation --- solid-state NMR --- ELDOR-detected NMR --- ATP hydrolysis --- ATP analogues --- DnaB helicase --- ABC transporter --- biopesticides --- antifungal activity --- insecticidal activity --- mechanism of action --- transgenic crops --- protein folding --- NMR --- High Hydrostatic Pressure --- ACE2 --- viral spike receptor-binding domain --- SARS-CoV-2 --- transmission --- bioinformatics --- IDP 1 --- binding 2 --- molecular dynamics 3 --- MELD×MD 4 --- advanced sampling 5 --- p53 6 --- MDM2 7 --- NAD(P)H-dependent oxidoreductase --- zinc-containing alcohol dehydrogenase --- cofactor binding and release --- interdomain cleft dynamics --- molecular dynamics simulations --- denatured state ensemble --- protein coil library --- peptides --- intrinsically disordered proteins --- ion-pairing interaction --- side-chain length --- charged amino acids --- β-hairpin --- peptide --- Friedman’s test --- backbone atom coordinate variances and uncertainties --- superimposition --- nanobody --- protein structure --- immunoglobulin domain --- n/a --- Friedman's test
Choose an application
Since first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, “Recent Advances in Antibody Therapeutics”, presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies
Research & information: general --- Chemistry --- interleukin 33 --- ST2 receptor --- scFv --- C2_2E12 --- bladder cancer --- antibodies --- immune checkpoint inhibitors --- antibody-drug conjugates --- sacituzumab govitecan --- enfortumab vedotin --- erdafitinib --- cost-effectiveness --- G protein-coupled receptor --- membrane protein --- antigen --- therapeutic antibody --- anti-angiogenesis --- delta-like ligand --- irinotecan --- paclitaxel --- VEGF --- SARS-CoV-2 --- spike protein --- receptor-binding domain --- phage display --- monoclonal antibody --- cytomegalovirus --- peptide/major histocompatibility complex class I complex --- T-cell-receptor-like antibody --- affinity maturation --- yeast surface display --- combinatorial antibody library --- agonist antibody --- cell fate --- bispecific antibodies --- bioassays --- mechanisms of action --- binding assays --- potency assays --- atherosclerosis --- inflammation --- antibody therapy --- blood–brain barrier --- antibody --- pharmacokinetics --- disposition --- biochemical and physicochemical properties --- Fc binding --- receptor-mediated transcytosis --- brain shuttle --- molecular Trojan horse --- transferrin --- anti-cancer antibody --- antibody engineering --- biophysical properties --- computational methods --- research cell bank --- antibody therapeutics --- recombinant antibodies --- intracellular antibodies --- single-chain antibody fragment --- nanobody --- Human papillomaviruses --- HPV oncoproteins --- HPV-associated cancer --- HPV cancer therapy --- asthma --- refractory asthma --- biomarker --- n/a --- blood-brain barrier
Choose an application
Few neurotransmitter systems have fascinated as much as the opioid system (i.e., opioid ligands and their receptors). Over the years, scientific studies of the endogenous opioid system have uncovered a complex and subtle system that exhibits impressive diversity, based on its critical role in modulating a large number of sensory, motivational, emotional and cognitive functions. Additionally, its important therapeutic value for the treatment of many human disorders, including pain, affective and addictive disorders, and gastrointestinal motility disorders, has been of persistent interest. This book specifically covers a broad area of the opioid research, offering up-to-date and new perspectives about opioid drug discovery. The diversity among the discussed topics ranging from medicinal chemistry to opioid pharmacology, from basic science to translational research, is a testimony to the complexity of the opioid system that results from the expression, regulation and functional role of opioid ligands and their receptors. This book will serve as a useful reference to scientists while also stimulating continuous research in the chemistry and pharmacology of the opioid system, with the prospective for finding improved therapies of human diseases where the opioid system plays a central role.
Research & information: general --- Chemistry --- thiazole --- piperazine --- tail-clip --- hot-plate --- acetic acid-induced writhing test --- opioid --- prodynorphin --- epigenetics --- transcription --- human brain --- morphine dosing --- behavior --- locomotor activity --- tolerance --- µ-opioid receptor --- DAMGO --- SR-17018 --- buprenorphine --- nalbuphine --- kappa opioid receptor agonist --- pruritis --- scratching --- mice --- TAT-HIV --- cholestasis --- chloroquine --- deoxycholic acid --- analgesic --- δ opioid receptor --- G-protein-biased agonist --- opioid peptide --- rubiscolins --- µ-opioid analgesics --- angiotensin receptors --- chronic pain --- neuropathic pain --- delta opioid receptor --- inverse agonist --- irreversible antagonist --- non-competitive antagonist --- molecular pharmacology --- free fatty acid receptors --- lipids --- opioid receptor --- colitis --- chemotype --- high-throughput screen --- allosteric modulation --- beta-arrestin --- molecular dynamics --- opioid receptors --- β-amino acids --- peptide synthesis --- receptor binding studies --- functional assay --- nociceptin/orphanin FQ receptor --- NOP receptor --- ligands --- nociceptin --- N/OFQ --- analgesia --- GPCR --- HS-731 --- peripheral opioid agonist --- binding --- selectivity --- molecular docking --- molecular dynamics simulations --- n/a --- fluorescence cross-correlation spectroscopy (FCCS) --- G protein-coupled receptor (GPCR) --- serotonin
Choose an application
Proteins represent one of the most abundant classes of biological macromolecules and play crucial roles in a vast array of physiological and pathological processes. The knowledge of the 3D structure of a protein, as well as the possible conformational transitions occurring upon interaction with diverse ligands, are essential to fully comprehend its biological function.In addition to globular, well-folded proteins, over the past few years, intrinsically disordered proteins (IDPs) have received a lot of attention. IDPs are usually aggregation-prone and may form toxic amyloid fibers and oligomers associated with several human pathologies. Peptides are smaller in size than proteins but similarly represent key elements of cells. A few peptides are able to work as tumor markers and find applications in the diagnostic and therapeutic fields. The conformational analysis of bioactive peptides is important to design novel potential drugs acting as selective modulators of specific receptors or enzymes. Nevertheless, synthetic peptides reproducing different protein fragments have frequently been implemented as model systems in folding studies relying on structural investigations in water and/or other environments.This book contains contributions (seven original research articles and five reviews published in the journal Molecules) on the above-described topics and, in detail, it includes structural studies on globular folded proteins, IDPs and bioactive peptides. These works were conducted usingdifferent experimental methods.
mass spectrometric epitope mapping --- gas phase immune complex dissociation --- apparent gas phase dissociation constants --- apparent gas phase activation energies --- ITEM-TWO --- native mass spectrometry --- TRIOBP --- cancer --- deafness --- hearing loss --- mental illness --- schizophrenia --- actin --- cytoskeleton --- disordered structure --- protein aggregation --- solid-state NMR --- ELDOR-detected NMR --- ATP hydrolysis --- ATP analogues --- DnaB helicase --- ABC transporter --- biopesticides --- antifungal activity --- insecticidal activity --- mechanism of action --- transgenic crops --- protein folding --- NMR --- High Hydrostatic Pressure --- ACE2 --- viral spike receptor-binding domain --- SARS-CoV-2 --- transmission --- bioinformatics --- IDP 1 --- binding 2 --- molecular dynamics 3 --- MELD×MD 4 --- advanced sampling 5 --- p53 6 --- MDM2 7 --- NAD(P)H-dependent oxidoreductase --- zinc-containing alcohol dehydrogenase --- cofactor binding and release --- interdomain cleft dynamics --- molecular dynamics simulations --- denatured state ensemble --- protein coil library --- peptides --- intrinsically disordered proteins --- ion-pairing interaction --- side-chain length --- charged amino acids --- β-hairpin --- peptide --- Friedman’s test --- backbone atom coordinate variances and uncertainties --- superimposition --- nanobody --- protein structure --- immunoglobulin domain --- n/a --- Friedman's test
Choose an application
Since first receiving approval in 1986, antibody-based therapeutics have been the most successful modality for the treatment of various diseases. This Special Issue of IJMS, “Recent Advances in Antibody Therapeutics”, presents leading-edge articles and reviews for discovery, development, and clinical applications of therapeutic antibodies, covering antibody drug conjugates (ADCs), GPCR-targeting antibodies, a functional antibody screening, bioassay of bispecific antibodies, antibody applications for cardiovascular diseases, antibody delivery to CNS, etc. The excellent studies in this Special Issue would valuable insight for scientists and clinicians in the field of therapeutic antibodies
interleukin 33 --- ST2 receptor --- scFv --- C2_2E12 --- bladder cancer --- antibodies --- immune checkpoint inhibitors --- antibody-drug conjugates --- sacituzumab govitecan --- enfortumab vedotin --- erdafitinib --- cost-effectiveness --- G protein-coupled receptor --- membrane protein --- antigen --- therapeutic antibody --- anti-angiogenesis --- delta-like ligand --- irinotecan --- paclitaxel --- VEGF --- SARS-CoV-2 --- spike protein --- receptor-binding domain --- phage display --- monoclonal antibody --- cytomegalovirus --- peptide/major histocompatibility complex class I complex --- T-cell-receptor-like antibody --- affinity maturation --- yeast surface display --- combinatorial antibody library --- agonist antibody --- cell fate --- bispecific antibodies --- bioassays --- mechanisms of action --- binding assays --- potency assays --- atherosclerosis --- inflammation --- antibody therapy --- blood–brain barrier --- antibody --- pharmacokinetics --- disposition --- biochemical and physicochemical properties --- Fc binding --- receptor-mediated transcytosis --- brain shuttle --- molecular Trojan horse --- transferrin --- anti-cancer antibody --- antibody engineering --- biophysical properties --- computational methods --- research cell bank --- antibody therapeutics --- recombinant antibodies --- intracellular antibodies --- single-chain antibody fragment --- nanobody --- Human papillomaviruses --- HPV oncoproteins --- HPV-associated cancer --- HPV cancer therapy --- asthma --- refractory asthma --- biomarker --- n/a --- blood-brain barrier
Listing 1 - 10 of 17 | << page >> |
Sort by
|